Frequently Asked Questions
The market is segmented based on Global Next Generation DNA Sequencing (NGS) Market, By Product (Instruments, Consumables, Services), Applications (Diagnostics, Biomarker Discovery, Precision Medicine, Drug Discovery, Agriculture and Animal Research and Others), End User (Pharmaceutical and Biotechnology Companies, Research Centers and Academic and Government Institutes, Hospital and Clinics) – Industry Trends and Forecast to 2029.
.
The Global Next Generation Dna Sequencing Ngs Market size was valued at USD 9.40 USD Billion in 2021.
The Global Next Generation Dna Sequencing Ngs Market is projected to grow at a CAGR of 20% during the forecast period of 2022 to 2029.
The major players operating in the market include Illumina, Thermo Fisher Scientific, PerkinElmer, BGI Group, Agilent Technologies, Eurofins Scientific, PacBio, Oxford Nanopore Technologies, QIAGEN, F. Hoffmann La Roche, GENEWIZ, Psomagen, 10x Genomics, Takara Bio, BioRad Laboratories, Zymo Research Corporation, Tecan Trading AG, Hamilton Company, Beckman Coulter, BD, Lucigen Corporation, Novogene Co..
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America..
